Knight Therapeutics Reports First Quarter 2022 Results

12.05.2022 - MONTREAL, May 12, 2022 (GLOBE NEWSWIRE) - Knight Therapeutics Inc. (TSX: GUD) ('Knight' or “the Company”), a leading Pan-American (ex-US) specialty pharmaceutical company, today reported financial results for its first quarter ended March 31, ...

Related Keywords

Montreal ,Quebec ,Canada ,Colombia ,United States ,Argentina ,Philadelphia ,Pennsylvania ,Brazil ,Colombian ,Argentine ,America ,Canadian ,Brazilian ,American ,Robertn Lande ,Michaelj Tremblay ,Arvind Utchanah ,Janice Murray ,Samira Sakhia ,Jonathan Ross Goodman ,Leopoldo Bosano ,Biotoscana Farma ,Company Argentine ,Knight Therapeutics Inc ,Normal Course Issuer Bid ,Helsinn Healthcare ,Chief Executive Officer ,Knight Therapeutics ,Brazilian Real ,Forward Looking Statements ,Call Notice ,Toll Free ,Therapeutics Inc ,Latin American ,United Medical ,Annual Report ,Annual Information Form ,Financial Reporting ,Hyperinflation Economies ,Argentine Peso ,